Published by
Wenshi Wang Hepatitis E virus (HEV) infection can cause severe complications and high mortality in pregnant women, organ transplant recipients, patients with pre-existing liver disease and immunosuppressed patien...
Published by
Mohammad Khalid Parvez In the absence of a globally accessible HEV vaccine, peg-IFNα-2a and ribavirin are the only effective regimen of choice for acute hepatic failure and chronic hepatitis E. However, though ribavirin in...
Published by
Mohammad Khalid Parvez Globally, pegylated interferon-α and ribavirin are the only recommended antiviral agents for treating chronic hepatitis E patients. However, though ribavirin induces a sustained virologic response, s...
Published by
Andrea Palombieri Hepatitis E virus (HEV) infections constitute a significant health problem worldwide, with 4 major genotypes (HEV1-HEV4) being implicated in human infection/disease. HEV3 and HEV4 are considered zoono...
Published by
Ana Carolina Abrantes Currently, the infection of European wild boars with the Hepatitis E virus (HEV) is seen as an emerging Public Health concern. Humans may be in danger of contracting acute lethal hepatitis from foodbo...
Published by
Maria Belen Pisano Hepatitis E virus (HEV) is an emerging cause of viral hepatitis and several animals such as pigs, wild boars or deers, are considered a reservoir for the virus. HEV genotype 3 (HEV-3) has been reporte...
Published by
Santiago Mirazo Wildlife is considered an important factor in the emergence and spread of emerging and re-emerging infectious diseases that can ultimately impact human and animal health. It is estimated that 75% of e...
Published by
Siddharth Sridhar, JIANWEN SITU Human cases of Rocahepevirus ratti (HEV-C1) infection are increasingly reported worldwide. Serological tests for HEV-C1 infection are necessary for measuring the clinical burden of HEV-C1 on communiti...
Published by
Morgan Herod Hepatitis E virus (HEV) is a common cause of acute viral hepatitis (inflammation of the liver). Although the infection usually self-resolves in healthy people, occasionally it can lead to acute liver ...
Published by
Qiuwei Abdullah Pan HEV infection caused liver diseases are closely related to dysregulation of immune responses, especially inflammatory response. Macrophages play a central role in immunosurveillance of the healthy liv...
GHEP offers free membership for your better connection with the hepatitis E community
EVENTS
2023-04-28
2nd International HEV Symposium The meeting will be held from April 28 to 29, 2023, in London. The 2-day meeting will feature talks and presentations given on the latest updates on HEV epidemiology, diagnostics, treatment, laboratory research, and disease control.
More information: https://www.ivi.int/hev-symposium-2023/